CN105997649A - Breast enlarging composition - Google Patents
Breast enlarging composition Download PDFInfo
- Publication number
- CN105997649A CN105997649A CN201610447309.4A CN201610447309A CN105997649A CN 105997649 A CN105997649 A CN 105997649A CN 201610447309 A CN201610447309 A CN 201610447309A CN 105997649 A CN105997649 A CN 105997649A
- Authority
- CN
- China
- Prior art keywords
- compositions
- extract
- breast enlargement
- breast
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 210000000481 breast Anatomy 0.000 title abstract description 26
- 241000196324 Embryophyta Species 0.000 claims abstract description 11
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims abstract description 11
- 239000000284 extract Substances 0.000 claims description 24
- 206010006242 Breast enlargement Diseases 0.000 claims description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 235000021028 berry Nutrition 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 230000003750 conditioning effect Effects 0.000 claims description 5
- 239000003002 pH adjusting agent Substances 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- 239000000080 wetting agent Substances 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 3
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 3
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 claims description 3
- 229940036350 bisabolol Drugs 0.000 claims description 3
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 3
- 229960001631 carbomer Drugs 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 239000000787 lecithin Substances 0.000 claims description 3
- 229940067606 lecithin Drugs 0.000 claims description 3
- 235000010445 lecithin Nutrition 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 3
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 2
- 241000628997 Flos Species 0.000 claims description 2
- HPEUJPJOZXNMSJ-UHFFFAOYSA-N Methyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC HPEUJPJOZXNMSJ-UHFFFAOYSA-N 0.000 claims description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims description 2
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 abstract description 6
- 238000011161 development Methods 0.000 abstract description 2
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 229940073667 kigelia africana fruit extract Drugs 0.000 abstract 1
- 210000000038 chest Anatomy 0.000 description 28
- 238000012360 testing method Methods 0.000 description 21
- 210000000577 adipose tissue Anatomy 0.000 description 7
- 210000003486 adipose tissue brown Anatomy 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 210000000115 thoracic cavity Anatomy 0.000 description 6
- 235000002378 plant sterols Nutrition 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 210000001789 adipocyte Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000000686 essence Substances 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- 108700038399 PGC-1 Proteins 0.000 description 2
- 102000017946 PGC-1 Human genes 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 210000001593 brown adipocyte Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000007596 consolidation process Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000000636 white adipocyte Anatomy 0.000 description 2
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000014603 Kigelia pinnata Species 0.000 description 1
- 235000002329 Kigelia pinnata Nutrition 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229920000891 common polymer Polymers 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 235000015639 rosmarinus officinalis Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003153 stable transfection Methods 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to the technical field of cosmetics, and discloses a breast enlarging composition. The breast enlarging composition is prepared from at least three of acetyl hexapetide-38, kigelia Africana fruit extract, kudzu vine root essence and organic plant essence. The cosmetic composition can promote natural re-development of breasts, so that the breasts store more fat and are plumper and more elastic.
Description
Technical field
The present invention relates to cosmetic technical field, particularly one has and makes chest more plentiful, strong, increases
Add the compositions that chest is elastic.
Background technology
Abundant along with people's material life, spirit and beautiful pursuit are also constantly being promoted by people.By west
Fang Wenhua and aesthetic impact, the maintenance of stature is the most increasingly focused on by people.Have plentiful and substantial chest and
Very thin waist also becomes the dream of multifarious maiden, but reality is cruel eventually, according to investigations, and the female of 75%
Property oneself stature is unsatisfied with, it is desirable to change some position and make oneself to seem more attractive.And
Women wants most, in the position changed, chest to make the demand changed and ranks first the most always.At present, breast enlargement
Major way still perform the operation and enlarge the bosom, the material that breast enlargement uses is the most all the inert material such as paraffin, silica gel,
Although being easy to allow breast increase, but postoperative most of women there will be complication in various degree, then,
Occur in that again the mode of a kind of polyacrylamide hydrophilic gel of injection or autologous fat realizes the increase of chest.But
Operation breast enlargement never solves the embedded material compatibility and the problem of implant surgery pain, therefore, finds
A kind of breast enlargement class cosmetics, promote that growing the most again of breast is also that cosmetic industry is the most persistently studied
Problem.
Breast is in breastbone both sides, two the hemispherical tissues existed between skin and muscle, substantially
Being made up of lobes of mammary gland, connective tissue, fatty tissue and cooper's ligament, breast also contains abundant simultaneously
Blood vessel, nerve and lymphatic vessel.Wherein fatty tissue accounts for the major part of breast, is distributed in around gland leaf, gland
Between body and after muscle, the volume of fatty tissue the most substantially determines the size and shape of breast.Institute
With, the volume of fatty tissue can be increased by the quantity or fat content increasing adipose cell, from
And make chest plentiful, tall and straight, more flexible.
Human body subcutaneous fat cells has white adipocyte and brown fat cell, and white adipose is subcutaneous at human body
A large amount of existence, its effect is storage excess energy.White adipose too much can form obesity, and brown fat is then
Completely contrary, its not storing energy, but there is high metabolic rate, and by energy in the way of heat production
Consume.According to current research, the white adipose of human body there is also the brown fat of disperse, white adipose and
Brown fat is probably and is mixed, and simply proportion is different, as long as there is the portion of white adipocyte
Position all there may be brown fat cell.It addition, be also can be mutual between white adipose and brown fat
Convert, and white adipose is the main source forming brown fat.Therefore, specific part is suppressed
Brown fat, increases the enrichment of white adipose then so that this position can be by internal excess energy with fat
The form of fat stores, and makes human body more plentiful, compacts.
Research shows, the peptide molecule of some short chains with the differentiation of affecting lipocyte, thus can suppress particular portion
Position white adipose and the conversion of brown fat, make more white adipose deposit.At present, also have very
How about small-molecular peptides chain application cosmetic, promote skin firmness, reduce the correlational study of wrinkle.Base
In above-mentioned principle, it may be considered that this composition is used for breast enlargement product, chest is made to have more fat stores,
Make chest more plentiful, flexible.Meanwhile, also there are some researches show that some extracted form natural plant compositions contain greatly
Amount flavonoid and plant sterol, can stimulate human body to produce class hormone and estrogen secretion, can sting
Swash breast secondary development.
Summary of the invention
Present invention aim at providing a kind of breast enlargement product, in particular, it relate to a have make breast
Portion is more plentiful, strong, increases the elite product that chest is elastic.
For achieving the above object, the present invention adopts the following technical scheme that
The invention provides a have increase breast fat content, promote chest grow again breast enlargement combination
Thing.This breast enlargement compositions includes acetyl hexapeptide-38, Africa pendent lamp tree berry extract, Radix Puerariae elite and organic
In plant essence at least three kinds.
The breast enlargement compositions of the present invention all has for the growth of breast, the elastic improvement increased with breast curve
Significantly effect.
Accompanying drawing explanation
Fig. 1 is the compositions thoracic volume test result figure of user after 56 days using the present invention；
Fig. 2 is the compositions chest 3D rendering of user after 56 days using the present invention.
Detailed description of the invention
For making the technical problem to be solved in the present invention, technical scheme and beneficial effect clearer, with
Under in conjunction with specific embodiments, the present invention is described in detail.Should be appreciated that described herein specifically
Embodiment is only in order to explain the present invention rather than for limiting the present invention.
The invention provides a breast fat content that can increase, promote the breast enlargement compositions that chest is grown again,
It include acetyl hexapeptide-38, Africa pendent lamp tree (Kigelia Africana) berry extract, Radix Puerariae elite and
In organic plant elite at least three kinds.It is to say, according to an embodiment, said composition includes
In above-mentioned four kinds of materials three kinds.According to another embodiment, said composition include whole four kinds above-mentioned
Material.
According to one embodiment of present invention, said composition also can comprise wetting agent, skin conditioning agent, breast
One or more in agent, thickening agent, pH adjusting agent, preservative, essence.
According to one embodiment of present invention, the weight proportion of each constituent is: acetyl hexapeptide-38 accounts for group
Compound gross weight proportioning is 0-5%, and Africa pendent lamp tree berry extract accounts for 0-5%, and Radix Puerariae elite accounts for 0-3%,
Organic plant skims the cream off milk and accounts for 0-5%.It is to say, one therein can not be comprised, but can be comprised it
He is three kinds.Preferably, the minimum content of every kind of component is 0.1%.
According to one embodiment of present invention, this wetting agent includes but not limited to: hyaluronate sodium, ethoxy
Base diethylene glycol, butanediol, glycerol etc..
According to one embodiment of present invention, this skin conditioning agent includes but not limited to: bisabolol, general
Alcohol, lecithin.
According to one embodiment of present invention, this emulsifying agent includes but not limited to: PEG-20 methyl times
Semi-solid fat acid esters, PPG-26-butylol polyether-26, Cremophor RH40 etc..
According to one embodiment of present invention, this thickening agent includes but not limited to: acrylic acid (ester) class is common
Polymers sodium, carbomer etc..
According to one embodiment of present invention, this pH adjusting agent includes but not limited to aminomethyl propanol, Fructus Citri Limoniae
Acid etc..
The acetyl hexapeptide-38 that the compositions of the present invention is used is a kind of hexapeptide containing natural amino acid, is
By peptide combinatorial chemical method from 49, identifying out in the peptide storehouse of 521,980 hexapeptides, this combined peptide storehouse is to use
Gene analysis method is screened from the cell of stable transfection and is obtained, PGC-1 α promoter in this cell
The expression of activity control luciferase.Experiment in vitro confirms that acetyl hexapeptide-38 can be by improving PGC-1
α increases the differentiation of adipose cell in white adipose.Human experimentation confirms that acetyl hexapeptide-38 can increase white
Mature fat cell quantity in fatty tissue.Acetyl hexapeptide-38 can significantly increase Test sites (face
And chest) adipose tissue volume, can be used for increase specific part fatty tissue growth.
It is natural that the African pendent lamp tree berry extract that the compositions of the present invention uses is that one is grown on western part, Africa
Plant extract, rich in abundant flavonoid and plant sterol (class hormone) in extract, has stimulation
Chest grows function again, and local women is commonly used to consolidation and raises chest.Plant sterol and synthesizing steroid class
The tissue such as the adrenal gland of hormone, liver, testis and ovary has high affinity, it is taken as that it can conduct
The precursor of steroid hormone carrys out synthesizing steroid parahormone.The steroid of plant sterol is similar to that the knot of estrogen
Structure, this shows that plant sterol is likely to the activity with estrogen.This extract can use water extraction or
The mode of alcohol extraction, extracts acquisition in conventional manner.
Organic plant elite of the present invention comprises one or more in following plant component: Herba Centellae
(Centella Asiatica) extract, Rhizoma Polygoni Cuspidati (Polygonum Cuspidatum) root extract, Radix Scutellariae
(Scutellaria Baicalensis) root extract, tea (Camellia Sinensis) leaf extract, light fruit
Radix Glycyrrhizae (Glycyrrhiza Glabra) root extract, Flos Matricariae chamomillae (Chamomilla Recutita) flower extract,
Herba Rosmarini Officinalis (Rosmarinus Officinalis) extract.Described extract uses general extraction methods to obtain.
A specific embodiment according to the present invention, the weight proportion of each constituent in this breast enlargement compositions
For: acetyl hexapeptide-38 0-5%, Africa pendent lamp tree berry extract 0-5%, Radix Puerariae elite 0-3%, You Jizhi
Thing skims the cream off milk 0-5%, and wetting agent (includes but not limited to hyaluronate sodium, ethoxydiglycol, fourth two
Alcohol, glycerol etc.) 0.1-10%, skin conditioning agent (includes but not limited to bisabolol, pantothenylol, lecithin
Deng) 0.1-5%, emulsifying agent (includes but not limited to PEG-20 methyl sesquistearate, PPG-26-
Butylol polyether-26, Cremophor RH40 etc.) 0-3%, thickening agent (includes but not limited to acrylic acid
(ester) analog copolymer sodium, carbomer etc.) 0-2%, pH adjusting agent (include but not limited to aminomethyl propanol,
Citric acid etc.) 0-1.5%, preservative 0-3%, essence 0-1% and aqueous solvent surplus.
Embodiment 1-5
Table 1 below lists the concrete formula of breast enlargement composition product in embodiment 1-5:
Table 1 composite formula
Product using effect is tested:
1, thoracic volume test experiments:
Selected 32 female volunteers (25-40 year).According to the standard of selection, volunteer's chest measurement is at 80-90
Between, body weight is more stable.Volunteer's breast on one side uses blank product, and (matched group, this test uses to be protected
Wet frost), another side breast uses the composition product of the present invention, twice daily, each spread product 2-3g,
Massage 10 minutes, continuous 56 days.During on-test, 14 days, 28 days and use based on light when 56 days
The skin fast imaging techniques learning interferometric method measures thoracic volume.Comparative analysis experiment terminates and on-test
Time thoracic volume change, obtain the test data of Fig. 1.
Fig. 1 test result shows, patented product can substantially increase the volume of volunteer's chest, and uses
56 days thoracic volume incrementss of the composition product of the present invention are 30 times of reference product.
Fig. 2 is that wherein a volunteer in on-test and uses the 3D of 56 days potruncus of patented product to scheme
Picture.The 3D rendering of volunteer's chest when figure is on-test before wherein, rear figure is the 3D of 56 days potruncus
Image.This it appears that 56 days potruncus volumes significantly increase, and more plentiful, strong.
2, user experiences test:
Selected 40 female volunteers (25-40 year).According to the standard of selection, volunteer does not has obvious chest
Disease or skin sensitivity record.Volunteer is used as required this product, twice daily, smears product every time
Product 2-3g (smears whole chest and cervical region), and to chest massage 10 minutes, continuous 30 days.Then will
Hope person, according to oneself actual impression, fills in questionnaires.Questionnaire is from improving the chest degree of packing, improving skin consolidation
Degree, chest increase sense, skin elasticity is improved four dimensions and made investigation volunteer, and volunteer can select
Clearly, substantially, typically, the actual impression expressing oneself the most obvious, inconspicuous, test knot
Fruit is such as following table:
Table 2: volunteer's test result
Test result shows, the volunteer of more than 50% increases chest, Rosemary Extract and increase skin to this product
Effect in terms of skin elasticity pleases oneself.
3, clinical trial:
Selected 20 female volunteers (25-40 year).According to the standard of selection, volunteer does not has obvious chest
Disease or skin sensitivity record.Volunteer is used as required this product, twice daily, smears product every time
Product 2-3g, massages 10 minutes, continuous 28 days.
Test result:
The elasticity of a, the outward appearance of chest and muscle improves significantly with after test before testing, tests shirtfront
Portion is obvious sagging of flaccid muscles, during off-test, it is seen that chest is towering and breast rises, and breast is rich
Flexible, the curve of breast is the most plentiful.
B, chest opening angle:
Before test averagely: 72.4 degree
At the end of test averagely: 81.4 degree
Improve: the angle that 12.43% opens proves that thoracic curve has improvement.
From above clinical data it can be seen that the patented product is for the growth of breast, elastic increase and breast
The improvement of room curve all has obvious effect.
The present invention is not limited to above-mentioned detailed description of the invention, anyone the present invention enlighten under draw other
Product as any and present invention is same or like, within all falling within scope.
Claims (8)
1. a breast enlargement compositions, including acetyl hexapeptide-38, Africa pendent lamp tree berry extract, Radix Puerariae elite
With at least three kinds in organic plant elite.
Breast enlargement compositions the most according to claim 1, it is characterised in that: described acetyl hexapeptide-38
Accounting for composition total weight proportioning is 0-5%, and Africa pendent lamp tree berry extract accounts for composition total weight proportioning and is
0-5%, it is 0-3% that Radix Puerariae elite accounts for composition total weight proportioning, and organic plant skims the cream off milk, and to account for compositions total
Weight proportion is 0-5%.
Breast enlargement compositions the most according to claim 1, it is characterised in that: also include wetting agent, institute
State wetting agent and include hyaluronate sodium, ethoxydiglycol, butanediol and glycerol.
Breast enlargement compositions the most according to claim 1, it is characterised in that: also include skin conditioning agent,
Described skin conditioning agent includes bisabolol, pantothenylol and lecithin.
Breast enlargement compositions the most according to claim 1, it is characterised in that: also include emulsifying agent, institute
State emulsifying agent include PEG-20 methyl sesquistearate, PPG-26-butylol polyether-26 and
Cremophor RH40.
Breast enlargement compositions the most according to claim 1, it is characterised in that: also include thickening agent, institute
State thickening agent and include acrylic acid (ester) analog copolymer sodium and carbomer.
Breast enlargement compositions the most according to claim 1, it is characterised in that: also include pH adjusting agent,
Described pH adjusting agent includes aminomethyl propanol and citric acid.
Breast enlargement compositions the most according to claim 1, it is characterised in that: described organic plant elite
Comprise one or more in following plant component: Herba Centellae extract, polygoni cuspidati,radix extract, scutellariae,radix
Extract, Folium Camelliae sinensis extract, Glycyrrhiza glabra L. root extract, Flos Chrysanthemi extract and Herba Rosmarini Officinalis extract.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610447309.4A CN105997649A (en) | 2016-06-17 | 2016-06-17 | Breast enlarging composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610447309.4A CN105997649A (en) | 2016-06-17 | 2016-06-17 | Breast enlarging composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105997649A true CN105997649A (en) | 2016-10-12 |
Family
ID=57085438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610447309.4A Pending CN105997649A (en) | 2016-06-17 | 2016-06-17 | Breast enlarging composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105997649A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106798655A (en) * | 2017-02-24 | 2017-06-06 | 深圳市维琪医药研发有限公司 | A kind of peptide composition with function of breast augmentation |
| CN108685743A (en) * | 2018-08-16 | 2018-10-23 | 余荣华 | A kind of formula of chest enlarge product |
| CN108685800A (en) * | 2018-08-06 | 2018-10-23 | 广州市聚芳企业管理有限公司 | Promote estrogen secretion composition, lotion and preparation method thereof |
| CN109512762A (en) * | 2018-12-11 | 2019-03-26 | 广州市白云区天芳化妆品厂 | A kind of quantizing resonance high-frequency energy chest enlarge stoste and preparation method thereof |
| WO2019096957A1 (en) * | 2017-11-15 | 2019-05-23 | L'oreal | Composition comprising baicalin and a particular acrylic polymer |
| CN111346016A (en) * | 2020-04-22 | 2020-06-30 | 易金阳 | Application of fat cell peptide BMP-2C in preparing breast enlargement essence |
| CN111973518A (en) * | 2020-09-05 | 2020-11-24 | 梧州市华夏医药科技有限公司 | Activating and nourishing breast nursing emulsion and pleura patch prepared from same |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000002531A1 (en) * | 1998-07-10 | 2000-01-20 | C3D S.A.R.L. | Novel high viscosity cosmetic compositions to be applied on the skin |
| CN102670446A (en) * | 2012-05-22 | 2012-09-19 | 广州保税区雅兰国际化妆品有限公司 | Breast enlarging and beautifying additive for cosmetics |
-
2016
- 2016-06-17 CN CN201610447309.4A patent/CN105997649A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000002531A1 (en) * | 1998-07-10 | 2000-01-20 | C3D S.A.R.L. | Novel high viscosity cosmetic compositions to be applied on the skin |
| CN102670446A (en) * | 2012-05-22 | 2012-09-19 | 广州保税区雅兰国际化妆品有限公司 | Breast enlarging and beautifying additive for cosmetics |
Non-Patent Citations (3)
| Title |
|---|
| 《国产非特殊用途化妆品备案信息服务平台，网址：HTTP://125.35.6.80:8080/FTBA/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=2016030215085057RBX&NID=2016030215085057RBX》 * |
| 《新浪博客，网址：HTTP://BLOG.SINA.COM.CN/S/BLOG_1370A94220102VULV.HTML》 * |
| 《网址：HTTP://WWW.DOUBAN.COM/NOTE/524955163/?TYPE=REC》 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106798655A (en) * | 2017-02-24 | 2017-06-06 | 深圳市维琪医药研发有限公司 | A kind of peptide composition with function of breast augmentation |
| WO2019096957A1 (en) * | 2017-11-15 | 2019-05-23 | L'oreal | Composition comprising baicalin and a particular acrylic polymer |
| CN108685800A (en) * | 2018-08-06 | 2018-10-23 | 广州市聚芳企业管理有限公司 | Promote estrogen secretion composition, lotion and preparation method thereof |
| CN108685800B (en) * | 2018-08-06 | 2022-03-25 | 广州市聚芳企业管理有限公司 | Composition for promoting estrogen secretion, emulsion and preparation method thereof |
| CN108685743A (en) * | 2018-08-16 | 2018-10-23 | 余荣华 | A kind of formula of chest enlarge product |
| CN109512762A (en) * | 2018-12-11 | 2019-03-26 | 广州市白云区天芳化妆品厂 | A kind of quantizing resonance high-frequency energy chest enlarge stoste and preparation method thereof |
| CN111346016A (en) * | 2020-04-22 | 2020-06-30 | 易金阳 | Application of fat cell peptide BMP-2C in preparing breast enlargement essence |
| CN111973518A (en) * | 2020-09-05 | 2020-11-24 | 梧州市华夏医药科技有限公司 | Activating and nourishing breast nursing emulsion and pleura patch prepared from same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105997649A (en) | Breast enlarging composition | |
| CN102552096B (en) | Hair-blackening and hair-growing liquid shampoo and preparation method thereof | |
| CN101125119B (en) | Tibetan materia medica with whitening anti-senility function and application thereof | |
| CN106265478B (en) | It is a kind of to have effects that the skin care compositions of chest enlarge and its application | |
| CN107669564A (en) | It is a kind of that there is reparative regeneration, replenishing water and preserving moisture, the skin care compositions of anti-aging | |
| CN106798655B (en) | Polypeptide composition with breast enlargement effect | |
| CN110237104A (en) | It is suitable for the health-oriented products composition of adult female, old man and sub-health state crowd | |
| CN101623057A (en) | Chinese herbal medicine feed additive for stud rams | |
| CN102972872A (en) | Breast enlarging and beautifying anti-sag bra | |
| CN105919880A (en) | Breast enlargement and beauty cream | |
| CN105496831B (en) | Composition containing extract of centella asiatica, use thereof and external preparation for skin | |
| CN105125472A (en) | Nourishing and hair-blacking cream shampoo with natural extracts and preparation method of nourishing and hair-blacking cream shampoo | |
| CN101259095A (en) | Skin care products for neck and preparation technique thereof | |
| CN1311855C (en) | Officinal Dendrobium stem capsule and preparing method | |
| CN110075015A (en) | Aweto and its application and skin care item in skin care item | |
| CN107088183B (en) | A kind of cosmetic material and preparation method thereof | |
| CN101450033A (en) | Cosmetic of sexual senility resistant composition and preparation method thereof | |
| CN105411950A (en) | Whitening cosmetic containing pueraria extract, oat extract and medlar extract | |
| CN106916860A (en) | A kind of preparation method and applications of edible and medical fungi tunning | |
| CN102058513B (en) | Chinese herbal medicine crude solution and cosmetic containing same | |
| CN108042475A (en) | A kind of multiple-effect eye cream containing Flos persicae extract | |
| CN103271338B (en) | Composition with refreshing function and preparation method thereof | |
| CN103468407A (en) | Plant essential oil composition and bra | |
| CN110384636A (en) | A kind of U.S. chest consolidation massage cream and preparation method thereof containing Cananga odorata quintessence oil | |
| CN106137914A (en) | For making compositions of frost containing yak milk composition and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161012 |